Key Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Key Capital Management's MRK Position: Q2 2026 in Review
Key Capital Management increased its Merck (MRK) stake by 33% in Q2 2026, buying an estimated $1.87K and bringing the position to 65 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #362.
Key Capital Management first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.4K in Q4 2025. 2,371 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Key Capital Management held 65 shares of Merck worth $8.35K as of Q2 2026.
- Key Capital Management bought 16 Merck shares in Q2 2026, an estimated $1.87K.
- Merck made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #362 holding.
- Key Capital Management first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
- Key Capital Management's Merck position peaked at $10.4K in Q4 2025.
- 2,371 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.